Sort
30,917 grants matching “tumor microenvironment”
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
$410,341Raymond J Budde · Houston Pharmaceuticals, Inc. · R44 · FY2011 · AI
Skin Stem Cells and Their Niche Interactions
$410,337Elaine Fuchs · Rockefeller University · R01 · FY2024 · AR
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
$410,323David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Development of Angiogenesis Inhibitors
$410,239William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$410,221Fumito Ito · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Engineering Nanomaterials to Prime Immunity
$410,177James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
$410,155Sukyung Woo · State University Of New York At Buffalo · R01 · FY2024 · CA
3D High Density Collagen I Improves Modeling of Metastatic Pancreatic Cancer
$410,115Rebekah White · University Of California, San Diego · R21 · FY2025 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$410,108Gang Zhou · Augusta University · R01 · FY2024 · CA
Cell Death and Clonal Survival in Myelodysplastic Syndr*
$410,088H. Joachim Deeg · Fred Hutchinson Cancer Research Center · R01 · FY2007 · HL
Cell Death and Clonal Survival in Myelodysplastic Syndr*
$410,088H. Joachim Deeg · Fred Hutchinson Cancer Research Center · R01 · FY2008 · HL
Regulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity
$410,082Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2023 · AI
Regulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity
$410,082Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2024 · AI
Project 2: Sexual Dimorphism of Iron Metabolism in GBM
$410,080James R Connor · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$410,049Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2021 · CA
Gene set analysis of single cell genomics
$410,000Hildreth Frost · Dartmouth College · R35 · FY2023 · GM
The Role of Lumican in the cornea
$410,000Shukti Chakravarti · Johns Hopkins University · R01 · FY2009 · EY
Gene set analysis of single cell genomics
$410,000Hildreth Frost · Dartmouth College · R35 · FY2024 · GM
Gene set analysis of single cell genomics
$410,000Hildreth Frost · Dartmouth College · R35 · FY2025 · GM
The Role of Lumican in the cornea
$410,000Shukti Chakravarti · Johns Hopkins University · R01 · FY2008 · EY
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer
$409,948Roberta Faccio · Washington University · R01 · FY2023 · CA
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$409,870Marxa L. Figueiredo · Purdue University · R01 · FY2020 · CA
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$409,830Ji Ming Wang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
$409,733Victoria Jane Findlay · Virginia Commonwealth University · R01 · FY2022 · CA
A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts
$409,700Bahram A. Parvin · University Of Nevada Reno · R01 · FY2024 · CA